LEGN (Legend Biotech) Accounts Payable & Accrued Expense : $202.8 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Accounts Payable & Accrued Expense?

Legend Biotech's quarterly accounts payable & accrued expense increased from Mar. 2024 ($182.8 Mil) to Jun. 2024 ($215.6 Mil) but then declined from Jun. 2024 ($215.6 Mil) to Sep. 2024 ($202.8 Mil).

Legend Biotech's annual accounts payable & accrued expense increased from Dec. 2021 ($140.1 Mil) to Dec. 2022 ($226.8 Mil) but then declined from Dec. 2022 ($226.8 Mil) to Dec. 2023 ($160.2 Mil).

Legend Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Legend Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Accounts Payable & Accrued Expense Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

80.44

113.82

140.09

226.77

160.17

Legend Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															171.68	160.17	182.77	215.59	202.84

Legend Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Legend Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

9LB:Germany

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.